P0846ESA HYPORESPOSIVENESS AND CLINICAL OUTCOMES DURING TREATMENT WITH EPOETIN BETA PEGOL IN HEMODIALYSIS PATIENTS: A MULTICENTER PROSPECTIVE STUDY; PARAMOUNT-HD STUDY

Background and Aims Hemodialysis (HD) patients hyporesponsive to erythropoiesis stimulating agents (ESAs) were reported to have poor prognosis. However, little is known regarding the association between the hyporesponsiveness to CERA and the types of outcome in HD patients. Moreover, the effect of on-line HDF on hyporesponsiveness to CERA has not been evaluated so far. Method In this multicenter prospective study, we enrolled 4034 maintenance HD...